Hospital
Cape Canaveral Hospital, INC.
Cape Canaveral Hospital, INC. was paid $3.66M by Medicaid between Jan 2018 and Nov 2024, across 120 billing codes. Its largest line is 99284, emergency room visit (serious) — 25% of everything it billed.
33Billing provider infoCAPE CANAVERAL HOSPITAL, INC.
COCOA BEACH, FL 32931
COCOA BEACH, FL 32931
33aNPI1184691610assigned 03/03/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$3.66M
24GClaims172,426
24DCodes billed120
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other General Acute Care Hospital providers in Florida
Rank by total paid#93 of 163
Median peer was paid$4.77M
This provider vs. median0.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official PULIO, KRISTEN controls 12+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,139 | $161K | |
| 2019 | 40,442 | $577K | |
| 2020 | 29,684 | $482K | |
| 2021 | 34,541 | $623K | |
| 2022 | 37,047 | $996K | |
| 2023 | 16,225 | $658K | |
| 2024incomplete | 2,348 | $161K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 25% | 10,840 | 9,482 | $928K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 25% | 10,880 | 9,969 | $901K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12% | 5,270 | 4,388 | $454K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5.6% | 2,335 | 2,178 | $205K |
| 36415 | Collection of venous blood by venipuncture | 5.2% | 11,580 | 8,515 | $190K |
| 80053 | Comprehensive metabolic panel | 3.2% | 13,592 | 10,895 | $117K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.3% | 1,587 | 1,421 | $86K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.0% | 2,070 | 1,729 | $74K |
| 87430 | 1.3% | 849 | 796 | $49K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.3% | 739 | 645 | $48K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.2% | 1,232 | 1,108 | $43K |
| 87400 | 1.1% | 1,311 | 1,166 | $38K |
108 more codes
| 81001 | <1% | 6,822 | $32K | |
| 81003 | <1% | 1,878 | $31K | |
| 87088 | <1% | 3,039 | $28K | |
| 71045 | Radiologic examination, chest; single view | <1% | 4,722 | $24K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,202 | $24K |
| 59025 | Fetal non-stress test | <1% | 721 | $23K |
| 84484 | <1% | 3,171 | $20K | |
| 86900 | <1% | 600 | $20K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,072 | $17K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 623 | $16K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,399 | $16K |
| 85610 | <1% | 1,853 | $15K | |
| A9270 | Non-covered item or service | <1% | 12,318 | $14K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 137 | $14K |
| 85027 | <1% | 2,206 | $13K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 12,693 | $13K |
| J2704 | Injection, propofol, 10 mg | <1% | 1,122 | $13K |
| 85730 | <1% | 1,318 | $12K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 529 | $11K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 129 | $11K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,110 | $11K |
| 86901 | <1% | 602 | $11K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 994 | $10K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 4,382 | $9K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 155 | $7K |
| 81025 | <1% | 2,658 | $7K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 1,412 | $7K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 657 | $7K |
| 99218 | <1% | 310 | $6K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,871 | $6K |
| 87486 | <1% | 1,237 | $5K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 434 | $5K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,366 | $5K |
| 93041 | <1% | 1,979 | $3K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 2,126 | $3K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 98 | $3K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 29 | $3K |
| 73610 | <1% | 55 | $3K | |
| 83690 | <1% | 2,833 | $3K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,903 | $3K |
| 93975 | <1% | 164 | $3K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 121 | $3K |
| 80061 | Lipid panel | <1% | 1,607 | $2K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,290 | $2K |
| 73562 | <1% | 50 | $2K | |
| 84702 | <1% | 580 | $2K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 224 | $2K |
| 94760 | <1% | 575 | $2K | |
| 86850 | <1% | 101 | $1K | |
| 87081 | <1% | 977 | $1K | |
| 83735 | <1% | 1,646 | $1K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 354 | $1K |
| 87040 | <1% | 611 | $1K | |
| 87210 | <1% | 125 | $988.30 | |
| 76801 | <1% | 62 | $951.42 | |
| 87631 | <1% | 14 | $869.09 | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 73 | $864.19 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 359 | $863.18 |
| 87077 | <1% | 60 | $852.71 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 73 | $836.07 |
| 94664 | <1% | 906 | $811.18 | |
| 82947 | <1% | 18 | $789.20 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 471 | $771.53 |
| 83880 | <1% | 561 | $578.09 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 286 | $533.51 |
| 83605 | <1% | 533 | $503.39 | |
| 87420 | <1% | 289 | $485.19 | |
| 87186 | <1% | 1,039 | $411.97 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 244 | $352.65 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 131 | $307.01 |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 12 | $302.41 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,383 | $286.60 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 253 | $242.78 |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 33 | $234.52 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 22 | $212.25 |
| 76830 | Ultrasound, transvaginal | <1% | 14 | $209.06 |
| 84703 | <1% | 765 | $204.59 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 896 | $191.90 |
| 82077 | <1% | 204 | $177.98 | |
| 73630 | <1% | 74 | $174.37 | |
| 93971 | <1% | 41 | $141.37 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 1,237 | $112.51 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 372 | $108.68 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 57 | $102.38 |
| 86140 | <1% | 61 | $101.43 | |
| 82607 | <1% | 110 | $79.91 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 232 | $78.93 |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 15 | $67.91 |
| 85379 | <1% | 113 | $67.74 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 29 | $45.78 |
| 87581 | <1% | 1,237 | $40.33 | |
| 82043 | <1% | 17 | $39.68 | |
| J1790 | Injection, droperidol, up to 5 mg | <1% | 30 | $33.44 |
| 96376 | <1% | 162 | $32.48 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 997 | $7.87 |
| 86308 | <1% | 14 | $6.05 | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 15 | $6.03 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 87 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 52 | $0.00 |
| 85007 | 0% | 16 | $0.00 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 0% | 13 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 19 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 24 | $0.00 |
| 82550 | 0% | 13 | $0.00 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 79 | $0.00 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 88 | $0.00 |
| G0378 | Hospital observation service, per hour | 0% | 33 | $0.00 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPULIO, KRISTEN (EVP CFO)
| Provider | Location | Paid |
|---|---|---|
| Holmes Regional Medical Center, INC. | Melbourne, FL | $12.33M |
| Adventist Healthcare Fort Washington Medical Center INC | Ft Washington, MD | $8.63M |
| Holmes Regional Medical Center, INC | Palm Bay, FL | $7.24M |
| Hospice of Health First INC. | West Melbourne, FL | $4.13M |
| Viera Hospital INC | Melbourne, FL | $2.04M |
| Blackwell Physicians, LLC | Rockville, MD | $1.94M |
| Adventist Physician Services, INC. | Rockville, MD | $405K |
| Adventist Physician Services, INC. | Takoma Park, MD | $79K |
| Holmes Regional Medical Center, INC. | Melbourne, FL | $25K |
| Adventist Physician Services, INC. | Germantown, MD | $5K |
| Doctors Gi Partnership LTD | Palm Bay, FL | $932.71 |
| Cape Canaveral Hospital, INC. | Melbourne, FL | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.